Cargando…
Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy
Immune checkpoint molecules, also known as cosignaling molecules, are pivotal cell-surface molecules that control immune cell responses by either promoting (costimulatory molecules) or inhibiting (coinhibitory molecules) a signal. These molecules have been studied for many years. The application of...
Autores principales: | Wu, Baokang, Zhong, Chongli, Lang, Qi, Liang, Zhiyun, Zhang, Yizhou, Zhao, Xin, Yu, Yang, Zhang, Heming, Xu, Feng, Tian, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390200/ https://www.ncbi.nlm.nih.gov/pubmed/34433460 http://dx.doi.org/10.1186/s13046-021-02068-5 |
Ejemplares similares
-
CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis
por: Li, Yang, et al.
Publicado: (2022) -
Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways
por: Wu, Baokang, et al.
Publicado: (2021) -
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022) -
Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis
por: Niethammer, Philipp, et al.
Publicado: (2002) -
Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer
por: Lv, Chao, et al.
Publicado: (2022)